Aprocess measureassesses how well healthcare personnel follow specific procedures known to prevent infection. In the case of CAUTI (Catheter-Associated Urinary Tract Infection), monitoringstaff compliance with proper insertion techniqueis a direct process measure.
* According to theAPIC/JCR Workbook, effective CAUTI prevention involves evaluating compliance with proper catheter insertion and maintenance practices. Monitoring this behavior is a process measure that directly affects outcomes like infection rate reduction.
* TheCBIC Study Guidealso emphasizes usingcompliance with evidence-based insertion techniques as a strategy to measure and improve CAUTI prevention efforts.
* APIC Textnotes that “a process measure focuses on a process or the steps in a process that leads to a specific outcome.” This includes monitoring healthcare staff performance related to proper catheter insertion and care.
* Incorrect answer rationale:
* A. CAUTI rate per 1000 catheter days- This is anoutcome measure, not a process measure.
* B. Standardized Infection Ratio per unit- Also anoutcome/benchmarking metric.
* C. Rate of bloodstream infections secondary to CAUTI- This is anoutcome, not a process.
References:
APIC/JCR Infection Prevention and Control Workbook, 4th Edition, Chapter 12 – CAUTI Assessment APIC Text, 4th Edition, Chapter 17 – Performance Measures CBIC Study Guide, 6th Edition, Core Competency: Surveillance and Epidemiologic Investigation

When reviewing the discussion section of an original article, an infection preventionist must focus on critically evaluating the interpretation of the study findings, their relevance to infection control, and their implications for practice. The discussion section typically addresses the meaning of the results, compares them to existing literature, and considers limitations or alternative interpretations. The appropriate question should align with the purpose of this section and reflect the infection preventionist’s need to assess the validity and applicability of the research. Let’s analyze each option:
A). Was the correct sample size and analysis method chosen?: This question pertains to the methodology section of a research article, where the study design, sample size, and statistical methods are detailed. While these elements are critical for assessing the study’s rigor, they are not the primary focus of the discussion section, which interprets results rather than re-evaluating the study design. An infection preventionist might ask this during a review of the methods section, but it is less relevant here.
B). Could alternative explanations account for the observed results?: The discussion section often explores whether the findings can be explained by factors other than the hypothesized cause, such as confounding variables, bias, or chance. This question is highly appropriate for an infection preventionist, as it encourages a critical assessment of whether the results truly support infection control interventions or if other factors (e.g., environmental conditions, patient factors) might be responsible. This aligns with CBIC’s emphasis on evidence-based practice, where understanding the robustness of conclusions is key to applying research to infection prevention strategies.
C). Is the study question important, appropriate, and stated clearly?: This question relates to the introduction or background section of an article, where the research question and its significance are established. While important for overall study evaluation, it is not specific to the discussion section, which focuses on interpreting results rather than revisiting the initial question. An infection preventionist might consider this earlier in the review process, but it does not fit the context of the discussion section.
D). Are criteria used to measure the exposure and the outcome explicit?: This question is relevant to the methods section, where the definitions and measurement tools for exposures (e.g., a specific intervention) and outcomes (e.g., infection rates) are described. The discussion section may reference these criteria but focuses more on their implications rather than their clarity. This makes it less appropriate for the discussion section specifically.
The discussion section is where authors synthesize their findings, address limitations, and consider alternative explanations, making option B the most fitting. For an infection preventionist, evaluating alternative explanations is crucial to ensure that recommended practices (e.g., hand hygiene protocols or sterilization techniques) are based on solid evidence and not confounded by unaddressed variables. This critical thinking is consistent with CBIC’s focus on applying research to improve infection control outcomes.
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain I:
Identification of Infectious Disease Processes, which emphasizes critical evaluation of research evidence.
CBIC Examination Content Outline, Domain V: Management and Communication, which includes assessing the validity of research findings for infection control decision-making.

Before initiating airborne precautions, theinfection preventionist must first confirm the clinical suspicion of active TB.
Step-by-Step Justification:
* Confirming Active TB:
* Apositive tuberculin skin test (TST) alone does not indicate active disease.
* A review ofchest X-ray, symptoms, and risk factorsis needed.
* Medical Record Review:
* Past TB history, imaging, and sputum testingare key to diagnosis.
* Not all TST-positive patients require isolation.
Why Other Options Are Incorrect:
* A. Contact the roommate’s physician to initiate TST:Premature, asno confirmation of active TB existsyet.
* C. Report findings to Employee Health for staff follow-up:Should occuronly after TB confirmation
.
* D. Transfer to airborne isolation immediately:Airborne isolation is necessaryonly if active TB is suspected based on clinical findings.
CBIC Infection Control References:

The correct answer is A, “Type of floor material,” as it is the least important operating suite design feature for the prevention of infection compared to the other options. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the design of operating suites plays a critical role in infection prevention, particularly for surgical site infections (SSIs). While the type of floor material (e.g., vinyl, tile, or epoxy) can affect ease of cleaning and durability, its impact on infection prevention is secondary to other design elements that directly influence air quality, hygiene practices, and personnel movement (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.5 – Evaluate the environment for infection risks). Modern flooring materials are generally designed to be non-porous and easily disinfected, mitigating their role as a primary infection risk factor when proper cleaning protocols are followed.
Option B (positive pressure air handling) is highly important because it prevents the influx of contaminated air into the operating suite, reducing the risk of airborne pathogens, including those causing SSIs. This is a standard feature in operating rooms to maintain a sterile environment (AORN Guidelines for Perioperative Practice, 2023). Option C (placement of sinks for surgical scrubs) is critical for ensuring that surgical staff can perform effective hand and forearm antisepsis, a key step in preventing SSIs by reducing microbial load before surgery. Option D (control of traffic and traffic flow patterns) is essential to minimize the introduction of contaminants from outside the operating suite, as excessive or uncontrolled movement can increase the risk of airborne and contact transmission (CDC Guidelines for Environmental Infection Control in Healthcare Facilities, 2019).
The relative unimportance of floor material type stems from the fact that infection prevention relies more on consistent cleaning practices and the aforementioned design features, which directly address pathogen transmission routes. This aligns with CBIC’s focus on evaluating environmental risks based on their direct impact on infection control (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.4 – Implement environmental cleaning and disinfection protocols).
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.4 – Implement environmental cleaning and disinfection protocols, 3.5 – Evaluate the environment for infection risks. AORN Guidelines for Perioperative Practice, 2023. CDC Guidelines for Environmental Infection Control in Healthcare Facilities, 2019.

To determine which water type is suitable for drinking yet may still pose a risk for disease transmission, we need to evaluate each option based on its definition, treatment process, and potential for contamination, aligning with infection control principles as outlined by the Certification Board of Infection Control and Epidemiology (CBIC).
* A. Purified water: Purified water undergoes a rigorous treatment process (e.g., reverse osmosis, distillation, or deionization) to remove impurities, contaminants, and microorganisms. This results in water that is generally safe for drinking and has a very low risk of disease transmission when properly handled and stored. However, if the purification process is compromised or if contamination occurs post-purification (e.g., due to improper storage or distribution), there could be a theoretical risk.
Nonetheless, purified water is not typically considered a primary source of disease transmission under standard conditions.
* B. Grey water: Grey water refers to wastewater generated from domestic activities such as washing dishes, laundry, or bathing, which may contain soap, food particles, and small amounts of organic matter. It is not suitable for drinking due to its potential contamination with pathogens (e.g., bacteria, viruses) and chemicals. Grey water is explicitly excluded from potable water standards and poses a significant risk for disease transmission, making it an unsuitable choice for this question.
* C. Potable water: Potable water is water that meets regulatory standards for human consumption, as defined by organizations like the World Health Organization (WHO) or the U.S. Environmental Protection Agency (EPA). It is treated to remove harmful pathogens and contaminants, making it safe for drinking under normal circumstances. However, despite treatment, potable water can still pose a risk for disease transmission if the distribution system is contaminated (e.g., through biofilms, cross- connections, or inadequate maintenance of pipes). Outbreaks of waterborne diseases like Legionnaires’ disease or gastrointestinal infections have been linked to potable water systems, especially in healthcare settings. This makes potable water the best answer, as it is suitable for drinking yet can still carry a risk under certain conditions.
* D. Distilled water: Distilled water is produced by boiling water and condensing the steam, which removes most impurities, minerals, and microorganisms. It is highly pure and safe for drinking, often used in medical and laboratory settings. Similar to purified water, the risk of disease transmission is extremely low unless contamination occurs after distillation due to improper handling or storage. Like purified water, it is not typically associated with disease transmission risks in standard use.
The key to this question lies in identifying a water type that is both suitable for drinking and has a documented potential for disease transmission. Potable water fits this criterion because, while it is intended for consumption and meets safety standards, it can still be a vector for disease if the water supply or distribution system is compromised. This is particularly relevant in infection control, where maintaining water safety in healthcare facilities is a critical concern addressed by CBIC guidelines.
References:
* CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain III:
Prevention and Control of Infectious Diseases, which highlights the importance of water safety and the risks of contamination in potable water systems.
* CBIC Examination Content Outline, Domain IV: Environment of Care, which includes managing waterborne pathogens (e.g., Legionella) in potable water supplies.

In operating rooms,a minimum of 15 air changes per hour (ACH)is required, withat least 3 of those ACH being from fresh or outdoor air. This requirement helps reduce microbial contamination and provides a clean surgical environment.
* According to theAPIC Text:
“In each, air should flow out of the room and the minimum ACH should be 15, withthree of these ACH being fresh or outdoor air.”
* This aligns with design specifications outlined in the 2006 Guidelines for design and construction of health care facilities.
References:
APIC Text, 4th Edition, Chapter 116 – HVAC Systems

The Certification Study Guide (6th edition) describes surveillance in infection prevention as a systematic method for collecting, analyzing, and interpreting health data, and it categorizes surveillance approaches based on scope and focus. The three recognized categories of surveillance are whole house surveillance, targeted surveillance, and a combination of both, making option D the correct answer.
Whole house surveillance involves monitoring infections across the entire healthcare facility. This approach provides a broad overview of infection trends but may lack depth in high-risk areas. Targeted surveillance, on the other hand, focuses on specific populations, locations, procedures, or devices-such as CLABSI in ICUs or SSIs following orthopedic surgery-where risk is highest or where prevention efforts are prioritized. A combination approach integrates both methods, allowing facilities to maintain broad situational awareness while dedicating resources to high-impact areas.
The study guide emphasizes that infection prevention programs should select surveillance categories based on risk assessment, available resources, regulatory requirements, and organizational priorities. CIC exam questions often test understanding of surveillance structure rather than timing (prospective vs. retrospective) or purpose (baseline vs. benchmark), which are surveillance methods or uses, not categories.
Recognizing whole house, targeted, and combination surveillance as the core categories reflects foundational infection prevention principles and supports effective program design, evaluation, and regulatory compliance.
Reference: Certification Study Guide (CBIC/CIC Exam Study Guide), 6th edition, Chapter 4: Surveillance and Epidemiologic Investigation.

In operating rooms, a minimum of 15 air changes per hour (ACH) is required, with at least 3 of those ACH being from fresh or outdoor air. This requirement helps reduce microbial contamination and provides a clean surgical environment.
According to the APIC Text:
“In each, air should flow out of the room and the minimum ACH should be 15, with three of these ACH being fresh or outdoor air.” This aligns with design specifications outlined in the 2006 Guidelines for design and construction of health care facilities.
References:
APIC Text, 4th Edition, Chapter 116 – HVAC Systems

Postoperative infections in clean surgical operations, defined by the Centers for Disease Control and Prevention (CDC) as uninfected operative wounds with no inflammation and no entry into sterile tracts (e.g., gastrointestinal or respiratory systems), are influenced by various perioperative factors. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes identifying and mitigating risk factors in the “Prevention and Control of Infectious Diseases” domain, aligning with CDC guidelines for surgical site infection (SSI) prevention. The question focuses on identifying a procedure not documented as a contributor to SSIs, requiring an evaluation of evidence-based risk factors.
Option C, “The use of iodophors for preoperative scrubs,” has not been documented to contribute to the development of postoperative infections in clean surgical operations. Iodophors, such as povidone-iodine, are antiseptic agents used for preoperative skin preparation and surgical hand scrubs. The CDC’s “Guideline for Prevention of Surgical Site Infections” (1999) and its 2017 update endorse iodophors as an effective method for reducing microbial load on the skin, with no evidence suggesting they increase SSI risk when used appropriately. Studies, including those cited by the CDC, show that iodophors are comparable to chlorhexidine in efficacy for preoperative antisepsis, and their use is a standard, safe practice rather than a risk factor.
Option A, “Prolonged preoperative hospital stay,” is a well-documented risk factor. Extended hospital stays prior to surgery increase exposure to healthcare-associated pathogens, raising the likelihood of colonization and subsequent SSI, as noted in CDC and surgical literature (e.g., Mangram et al., 1999). Option B,
“Prolonged length of the operations,” is also a recognized contributor. Longer surgical durations are associated with increased exposure time, potential breaches in sterile technique, and higher infection rates, supported by CDC data showing a correlation between operative time and SSI risk. Option D, “Shaving the site on the day prior to surgery,” has been documented as a risk factor. Preoperative shaving, especially with razors, can cause microabrasions that serve as entry points for bacteria, increasing SSI rates. The CDC recommends avoiding shaving or using clippers immediately before surgery to minimize this risk, with evidence from studies like those in the 1999 guideline showing higher infection rates with preoperative shaving.
The CBIC Practice Analysis (2022) and CDC guidelines focus on evidence-based practices, and the lack of documentation linking iodophor use to increased SSIs-coupled with its role as a preventive measure-makes Option C the correct answer. The other options are supported by extensive research as contributors to SSI development in clean surgeries.
References:
* CBIC Practice Analysis, 2022.
* CDC Guideline for Prevention of Surgical Site Infections, 1999, updated 2017.
* Mangram, A. J., et al. (1999). Guideline for Prevention of Surgical Site Infection. Infection Control and Hospital Epidemiology.

Peripherally inserted central catheter (PICC)-associated bloodstream infections (BSIs) are a significant concern in healthcare settings, and identifying factors contributing to their increase is critical for infection prevention. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes the
“Surveillance and Epidemiologic Investigation” and “Prevention and Control of Infectious Diseases” domains, which align with the Centers for Disease Control and Prevention (CDC) guidelines for preventing intravascular catheter-related infections. The question asks for the intervention most likely to have contributed to the rise in PICC-associated BSIs over four months, requiring an evaluation of each option based on evidence-based practices.
Option C, “Replacement of the intravenous administration sets every 72 hours,” is the most likely contributor to the increase. The CDC’s “Guidelines for the Prevention of Intravascular Catheter-Related Infections” (2017) recommend that intravenous administration sets (e.g., tubing for fluids or medications) be replaced no more frequently than every 72-96 hours unless clinically indicated (e.g., contamination or specific therapy requirements). Frequent replacement, such as every 72 hours as a routine practice, can introduce opportunities for contamination during the change process, especially if aseptic technique is not strictly followed. Studies cited in the CDC guidelines, including those by O’Grady et al. (2011), indicate that unnecessary manipulation of catheter systems increases the risk of introducing pathogens, potentially leading to BSIs. A change to a 72- hour replacement schedule, if not previously standard, could explain the observed increase over the past four months.
Option A, “Use of chlorhexidine skin antisepsis during insertion of the PICC,” is a recommended practice to reduce BSIs. Chlorhexidine, particularly in a 2% chlorhexidine gluconate with 70% alcohol solution, is the preferred skin antiseptic for catheter insertion due to its broad-spectrum activity and residual effect, as supported by the CDC (2017). This intervention should decrease, not increase, infection rates, making it an unlikely contributor. Option B, “Daily bathing adult intensive care unit patients with chlorhexidine,” is another evidence-based strategy to reduce healthcare-associated infections, including BSIs, by decolonizing the skin of pathogens like Staphylococcus aureus. The CDC and SHEA (Society for Healthcare Epidemiology of America) guidelines (2014) endorse chlorhexidine bathing in intensive care units, suggesting it should lower, not raise, BSI rates. Option D, “Use of a positive pressure device on the PICC,” aims to prevent catheter occlusion and reduce the need for frequent flushing, which could theoretically decrease infection risk by minimizing manipulation. However, there is no strong evidence linking positive pressure devices to increased BSIs; if improperly used or maintained, they might contribute marginally, but this is less likely than the impact of frequent tubing changes.
The CBIC Practice Analysis (2022) and CDC guidelines highlight that deviations from optimal catheter maintenance practices, such as overly frequent administration set replacements, can increase infection risk.
Given the four-month timeframe and the focus on an intervention’s potential negative impact, Option C stands out as the most plausible contributor due to the increased manipulation and contamination risk associated with routine 72-hour replacements.
References:
* CBIC Practice Analysis, 2022.
* CDC Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2017.
* O’Grady, N. P., et al. (2011). Guidelines for the Prevention of Intravascular Catheter-Related Infections. Clinical Infectious Diseases.
* SHEA Compendium, Strategies to Prevent Central Line-Associated Bloodstream Infections, 2014.

The standard way to report ventilator-associated pneumonia (VAP) rates is:

Why the Other Options Are Incorrect?
A). Ventilator-associated pneumonia rate of 2% – This does not use the correct denominator (ventilator days).
C). Postoperative pneumonia rate of 6% in SICU patients – Not relevant, as the data focuses on VAP, not postoperative pneumonia.
D). More information is needed regarding ventilator days per patient – The total ventilator days are already provided, so no additional data is required.
CBIC Infection Control Reference
APIC and NHSN recommend reporting VAP rates as cases per 1,000 ventilator days.

When an infection preventionist (IP) is informed of a measles outbreak in a nearby community, the immediate priority is to protect healthcare workers and patients from potential exposure, particularly in a healthcare setting where vulnerable populations are present. Working with Occupational Health, the IP must follow a structured approach to mitigate the risk of transmission, guided by principles from the Certification Board of Infection Control and Epidemiology (CBIC) and public health guidelines. Let’s evaluate each option to determine the first priority:
A). Isolate employees who have recently traveled to areas with measles outbreaks: Isolating employees who may have been exposed to measles during travel is an important infection control measure to prevent transmission within the facility. However, this action assumes that exposure has already occurred and requires identification of affected employees first. Without knowing the immunity status of the workforce, this step is reactive rather than preventive and cannot be the first priority.
B). Reassign employees who are pregnant from caring for patients with suspected measles: Reassigning pregnant employees is a protective measure due to the severe risks measles poses to fetuses (e.g., congenital rubella syndrome risks, though measles itself is more about maternal complications). This action is specific to a subset of employees and depends on identifying patients with suspected measles, which may not yet be confirmed. It is a secondary step that follows assessing overall immunity and exposure risks, making it inappropriate as the first priority.
C). Verify that employees in high-risk exposure areas of the facility have adequate immunity to measles:
Verifying immunity is the foundational step in preventing measles transmission in a healthcare setting.
Measles is highly contagious, and healthcare workers in high-risk areas (e.g., emergency departments, pediatric wards) are at increased risk of exposure. The CBIC and CDC recommend ensuring that all healthcare personnel have documented evidence of measles immunity (e.g., two doses of MMR vaccine, laboratory evidence of immunity, or prior infection) as a primary infection control strategy during outbreaks.
This step allows the IP to identify vulnerable employees, implement targeted interventions, and comply with occupational health regulations. It is the most proactive and immediate priority when an outbreak is reported in the community.
D). Set up a mandatory vaccination clinic in collaboration with Occupational Health and local public health partners: Establishing a vaccination clinic is a critical long-term strategy to increase immunity and control the outbreak. However, this requires planning, resource allocation, and coordination, which take time. It is a subsequent step that follows verifying immunity status to identify those who need vaccination. While important, it cannot be the first priority due to its logistical demands.
The first priority is C, as verifying immunity among employees in high-risk areas establishes a baseline to prevent transmission before reactive measures (e.g., isolation, reassignment) or broader interventions (e.g., vaccination clinics) are implemented. This aligns with CBIC’s focus on proactive risk assessment and occupational health safety during infectious disease outbreaks, ensuring a rapid response to protect the healthcare workforce and patients.
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain III:
Prevention and Control of Infectious Diseases, which prioritizes immunity verification during outbreaks.
CBIC Examination Content Outline, Domain IV: Environment of Care, which includes ensuring employee immunity as part of outbreak preparedness.
CDC Guidelines for Measles Prevention (2023), which recommend verifying healthcare worker immunity as the initial step during a measles outbreak.

Thawing raw meat at room temperature is a major food safety violation because it allows bacteria to multiply rapidly within the temperature danger zone (40-140°F or 4.4-60°C). Meat should always be thawed in the refrigerator, under cold running water, or in a microwave if cooked immediately.
Why the Other Options Are Incorrect?
* B. Using a cutting board to cut vegetables – This is safe as long as proper cleaning and sanitation procedures are followed.
* C. Maintaining hot food at 145°F (62.7°C) during serving – 145°F is an acceptable minimum temperature for certain meats like beef, fish, and pork.
* D. Discarding most perishable food within 72 hours – Many perishable foods, especially leftovers, should be discarded within 3 days, making this an appropriate practice.
CBIC Infection Control Reference
The APIC guidelines emphasize that raw meat should never be thawed at room temperature due to the risk of bacterial growth and foodborne illness.

To determine the infection rate per 100 procedures for total hip replacements, use the following formula:
A white paper with black text and numbers AI-generated content may be incorrect.

Thus, the correct answer is B. 2.9 per 100 procedures.
CBIC Infection Control Reference
The methodology of calculating SSI rates aligns with guidelines from the National Healthcare Safety Network (NHSN) and standardized infection ratio (SIR) models used for hospital-specific SSI rates.

The safe transport of biohazardous samples, such as infectious agents, clinical specimens, or diagnostic materials, is a critical aspect of infection prevention and control to prevent exposure and environmental contamination. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes adherence to regulatory and safety standards in the “Prevention and Control of Infectious Diseases” domain, which includes proper handling and shipping of biohazardous materials. The primary guideline governing this practice is the U.S. Department of Transportation (DOT) Hazardous Materials Regulations (HMR) and the International Air Transport Association (IATA) Dangerous Goods Regulations, which align with global biosafety standards.
Option A, “Ship using triple-containment packaging,” is the essential element of practice. Triple-containment packaging involves three layers: a primary watertight container holding the sample, a secondary leak-proof container with absorbent material, and an outer rigid packaging (e.g., a box) that meets shipping regulations.
This system ensures that biohazardous materials remain secure during transport, preventing leaks or breaches that could expose handlers or the public. The CDC and WHO endorse this method as a fundamental requirement for shipping Category A (high-risk) and Category B (moderate-risk) infectious substances, making it the cornerstone of safe transport practice.
Option B, “Electronically log and send via overnight delivery,” is a useful administrative and logistical step to track shipments and ensure timely delivery, but it is not the essential element. While documentation and rapid delivery are important for maintaining chain of custody and sample integrity, they are secondary to the physical containment provided by triple packaging. Option C, “Transport by an authorized biohazard transporter,” is a necessary step to comply with regulations, as only trained and certified transporters can handle biohazardous materials. However, this is contingent on proper packaging; without triple containment, transport authorization alone is insufficient. Option D, “Store in a cooler that is labeled as a health hazard,” may be part of preparation (e.g., maintaining sample temperature), but labeling alone does not address the containment or transport safety required during shipment. Coolers are often used, but the focus on labeling as a health hazard is incomplete without the triple-containment structure.
The CBIC Practice Analysis (2022) supports compliance with federal and international shipping regulations, which prioritize triple-containment packaging as the foundational practice to mitigate risks. The CDC’s Biosafety in Microbiological and Biomedical Laboratories (BMBL, 6th Edition, 2020) and IATA guidelines further specify that triple packaging is mandatory for all biohazardous shipments, reinforcing Option A as the correct answer.
References:
* CBIC Practice Analysis, 2022.
* CDC Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition, 2020.
* U.S. DOT Hazardous Materials Regulations (49 CFR Parts 171-180).
* IATA Dangerous Goods Regulations, 2023.

The Certification Study Guide (6th edition) emphasizes that process performance indicators directly linked to evidence-based practices are the most effective measures for reducing healthcare-associated infections such as CLABSI. Among the options listed, 100% compliance with the central line insertion bundle is the only indicator consistently demonstrated to reduce CLABSI rates.
Insertion bundles are standardized sets of practices that include proper hand hygiene, maximal sterile barrier precautions, use of appropriate skin antisepsis (preferably chlorhexidine), optimal catheter site selection, and daily review of line necessity. The study guide explains that reliable execution of these bundled practices addresses the most common routes of microbial entry at the time of line placement, which is a critical risk period for bloodstream infection.
The other options do not represent valid improvement indicators. Total parenteral nutrition is a known risk factor for CLABSI, not a prevention strategy. Use of povidone-iodine ointment at insertion sites is not recommended and may increase infection risk. Routine guidewire exchanges are discouraged because they do not reduce infection risk and may increase contamination.
Therefore, measuring and achieving full compliance with the insertion bundle is a meaningful, actionable performance indicator that aligns with CBIC exam expectations and infection prevention best practices.
Reference: Certification Study Guide (CBIC/CIC Exam Study Guide), 6th edition, Chapter 5: Preventing
/Controlling the Transmission of Infectious Agents; Chapter 4: Surveillance and Epidemiologic Investigation.
\